Should Black Women Be Screened for Breast Cancer at Younger Ages?

Why breast cancer screenings make a difference to mortality rates and what this means for Black women in the U.S.

Some organizations recommend black women should be added to the high-risk group for breast cancer, and should begin talking to a healthcare provider about breast cancer risk no later than age 30.

Updated on January 25, 2023

While there will always be an element of unpredictability with any form of cancer, people who are diagnosed with early-stage breast cancer generally have a much better prognosis than people who are diagnosed with cancer that has progressed to later stages.

While breast cancer staging is complex and takes into account many factors about a particular cancer, early-stage refers to breast cancers that have not spread beyond the breast. This is also sometimes referred to as a localized stage.

Routine screenings for breast cancer are the key to early detection.

Mammograms and mortality rates

The standard for breast cancer screenings is an exam called a mammogram or mammography. During this exam, a breast is pressed between two plates of glass and an x-ray of the breast is taken. The x-ray provides an image of the inner structure of the breast tissue, including any abnormalities.

Multiple studies have found that women who attend mammography screenings have a much lower risk of dying from breast cancer. The conclusion is that more cancers are discovered earlier, before a cancer has spread and become more difficult to treat.

Mammography screenings at earlier ages are also cited as one of the ways to lower mortality rates among Black women with breast cancer in the United States.

When compared with all racial and ethnic groups in the U.S., Black women have the highest breast cancer mortality rate. This means that a greater percentage of Black women with breast cancer die as a result of having breast cancer. Compared with white women, for example, the mortality rate for Black women is about 40 percent higher.

Why are mortality rates higher?

There are multiple factors that are believed to contribute to the higher mortality rate among Black women with breast cancer. Many of these factors have to do with access to care, including screenings.

  • Black women are much more likely to have triple-negative breast cancer (TNBC), an aggressive form of the disease that is more difficult to treat. Black women are also more likely to have comorbid conditions (such as hypertension, obesity, and diabetes) which can make TNBC more difficult to treat.
  • While the incidence of breast cancer is lower among Black women, it is higher in Black women under the age of 60. Breast cancer may be more aggressive and less responsive to treatment in younger women.
  • Some research shows that Black women who are diagnosed with breast cancer are less likely to have genetic testing for BRCA mutations. Identifying these mutations can help predict what cancer therapies will be most effective.
  • Black women are less likely to be diagnosed at the localized stage and more likely to be diagnosed with a cancer that has spread beyond the breast.

When should you start screening?

Recommendations on when to begin screening for breast cancer vary depending on the organization that is publishing the guidelines.

Some organizations recommend that Black women should begin screening at age 40. Others argue that Black women should be added to the high-risk group due to the factors mentioned above, and they should begin talking to a healthcare provider about breast cancer risk no later than age 30.

Breast cancer screenings starting at age 40 are covered by most insurance plans, including government insurance programs like Medicare and Medicaid (though what is covered can vary from state to state).

People without insurance may be able to access no-cost cancer screenings through the National Breast and Cervical Cancer Early Detection Program (NBCCEDP).

Article sources open article sources

National Cancer Institute. Early-stage breast cancer. Accessed January 24, 2023.
American Cancer Society. American Cancer Society Recommendations for the Early Detection of Breast Cancer. January 14, 2022.
MedlinePlus. Mammography. Last updated December 3, 2021.
Laszlo Tabar, Peter B. Dean, et al. The incidence of fatal breast cancer measures the increased effectiveness of therapy in women participating in mammography screening. Cancer, 2018. Vol. 125, No. 4.
Suzie J. Otto, Jacques Fracheboud, et al. Mammography Screening and Risk of Breast Cancer Death: A Population-Based Case–Control Study. Cancer Epidemiology, Biomarkers & Prevention, 2012. Vol. 21, No. 1.
Andrew Coldman, Norm Phillips, et al. Pan-Canadian Study of Mammography Screening and Mortality from Breast Cancer" Journal of the National Cancer Institute, 2014. Vol. 106, No. 11.
American Cancer Society. Key Statistics for Breast Cancer. Last revised January 12, 2023.
Laura Cowen. Earlier breast screening for Black women may reduce racial mortality gaps. Medicine Matters. October 20, 2021.
Murray Rebner and Vidya R. Pai. Breast Cancer Screening Recommendations: African American Women Are at a Disadvantage. Journal of Breast Imaging, 2020. Vo. 2, No. 5.
Centers for Disease Control and Prevention. Breast Cancer Statistics. Last reviewed June 6, 2022.
National cancer Institute Surveillance, Epidemiology, and End Results Program. Cancer Mortality Rates. Accessed January 24, 2023.
Richardson LC, Henley SJ, et al. Patterns and Trends in Age-Specific Black-White Differences in Breast Cancer Incidence and Mortality – United States, 1999–2014. M findings suggest that structural features of local health care systems, rather than variation in patient characteristics, may be key explanatory factors for geographic disparities in treatment delays and other cancer outcomes.MWR Morb Mortal Wkly Rep 2016;65:1093–1098.
Giaquinto AN, Sung H, et al. Breast Cancer Statistics, 2022. CA: A Cancer Journal for Clinicians. November/December 2022. Vol. 72, Issue 6. Pages 524-541.
Penn Medicine News. Black Women Face Three-Fold Increased Risk of Triple Negative Breast Cancers. September 20, 2021.
Eric C. Dietze, Christopher Sistrunk, et al. Triple-negative breast cancer in African-American women: disparities versus biology. Nature Reviews. Cancer, 2015. Vol. 15, No. 4.
Cleveland Clinic. Breast Cancer in Young Women. Reviewed September 18, 2019.
Tarsha Jones, Anne Marie McCarthy, Younji Kim, and Katrina Armstrong. Predictors of BRCA1/2 genetic testing among Black women with breast cancer: a population‐based study. Cancer Medicine, 2017. Vol. 6, No. 7.
National Cancer Institute. BRCA Gene Mutations: Cancer Risk and Genetic Testing. November 19, 2020.
Christina Chapman. Starting mammograms at 40 would reduce disparities in deaths for Black women. University of Michigan Health Lab. October 25, 2021.
Debra L. Monticciolo, Mary S. Newell, et al. Breast Cancer Screening in Women at Higher-Than-Average Risk: Recommendations From the ACR. Journal of the American College of Radiology, 2018. Vol. 15, No. 3.
Kaiser Family Foundation. Coverage of Breast Cancer Screening and Prevention Services. September 26, 2019.

Featured Content


Racial Disparities, Mortality Rates, and Breast Cancer

Black women are more likely to die from breast cancer than women of other races. Here’s what we know and don’t know.

Why Breast Cancer Clinical Trials Need More Diversity

In order to improve breast cancer outcomes, clinical trials need more women from racial and ethnic minorities.